On the transcriptional level, this supplement could not only inhibit the mRNA expression of TLR4 but also regulate the downstream inflammatory cytokines in the colitis model, containing the downregulation of proinflammatory cytokines IL-1β, IL-6, and TNF-α and the upregulation of anti-inflammatory cytokine IL-10. The gene discussed is TLR4; the disease is colitis.